<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fei X</submitter><funding>National Natural Science Foundation of China</funding><pagination>e0150025</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12688083</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(10)</volume><pubmed_abstract>As an alternative to the tuberculin skin test (TST) or QuantiFERON-TB Gold In-Tube (QFT-GIT), ESAT6-CFP10 (EC) skin test is an emerging screening method; however, its value in the diagnosis of latent tuberculosis infection (LTBI) in detainees is still unclear in China. Newly admitted detainees meeting inclusion criteria were enrolled, with demographic/clinical data collected via structured questionnaires. TST, EC skin test, and QFT-GIT screenings were performed, documenting the diameter of skin indurations and/or redness at injection sites and blistering reactions at injection sites. In total, 1,038 detainees were enrolled in this study from October 2022 to October 2023 with 236 LTBI (22.7%). The positive rate of TST, EC skin test, and QFT-GIT was 18.1%, 10.6% and 11.9%. The area under the</pubmed_abstract><journal>Microbiology spectrum</journal><pubmed_title>Diagnostic accuracy of the ESAT6-CFP10 skin test for latent tuberculosis infection among jail detainees.</pubmed_title><pmcid>PMC12688083</pmcid><funding_grant_id>82574172, 82003516</funding_grant_id><pubmed_authors>Martinez L</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Zhu L</pubmed_authors><pubmed_authors>Hu X</pubmed_authors><pubmed_authors>Tang P</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Fei X</pubmed_authors><pubmed_authors>Chen C</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Diagnostic accuracy of the ESAT6-CFP10 skin test for latent tuberculosis infection among jail detainees.</name><description>As an alternative to the tuberculin skin test (TST) or QuantiFERON-TB Gold In-Tube (QFT-GIT), ESAT6-CFP10 (EC) skin test is an emerging screening method; however, its value in the diagnosis of latent tuberculosis infection (LTBI) in detainees is still unclear in China. Newly admitted detainees meeting inclusion criteria were enrolled, with demographic/clinical data collected via structured questionnaires. TST, EC skin test, and QFT-GIT screenings were performed, documenting the diameter of skin indurations and/or redness at injection sites and blistering reactions at injection sites. In total, 1,038 detainees were enrolled in this study from October 2022 to October 2023 with 236 LTBI (22.7%). The positive rate of TST, EC skin test, and QFT-GIT was 18.1%, 10.6% and 11.9%. The area under the</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-05T23:45:14.963Z</modification><creation>2026-05-23T03:13:42.124Z</creation></dates><accession>S-EPMC12688083</accession><cross_references><pubmed>40960282</pubmed><doi>10.1128/spectrum.01500-25</doi></cross_references></HashMap>